Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collection (NIGMS)

• Published date: 03 December 2020
• DOI: http://doi.org/10.1002/fgc.31443
• Date: 03 December 2020

Page 8 Federal Grants & Contracts ■ December 3, 2020

© 2020 Wiley Periodicals LLC • All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

4 EASY WAYS TO ORDER

CALL Toll-Free: 800.835.6770

MAIL:

John Wiley & Sons Inc.

P.O. Box 55381

Boston, MA 02205-9850

EMAIL: cs-journals@wiley.com or

ONLINE AT: wileyonlinelibrary.com/journal/fgc

Wiley Guarantee: If you are not completely satisfied with this newsletter,

let us know and we will refund the cost of your subscription.

❑ YES! Please start my one-year subscription (24 issues) to

Federal Grants and Contracts for $446

PAYMENT OPTIONS: (all payments must be in U.S. dollars)

❑My Check payable to John Wiley & Sons is enclosed.

To make payment by credit card, please contact Customer Service 24 × 7

at +1-800-835-6770.

Name: ___________________________________________

Title: _____________________________________________

Company: _________________________________________

Address: __________________________________________

City: ____________________ State: ___ ZIP Code: ___________

Email: ___________________ Phone: ____________________

❑ Yes, I’d like to hear about special discount offers, new products, and more.

Place me on the Wiley email list.

Individual rate subscriptions must be paid by pe rsonal check or credit card. All orders subject

to credit approval. Price includes postage, packing, and handling charge s worldwide.

Canadian residents add GST and any local sales t ax. GST #128424017.

Individual-rate subscriptions may not be resol d or used as library copies.

a Phase I or Phase II trial in patients with LBD.

➜ www.grants.gov; FON# RFA-NS-21-008

Outstanding early stage postdoctoral

researchers (NCI)

Scope: The National Cancer Institute seeks (K99/R00)

applications for the NCI Pathway to Independence

Award for Outstanding Early Stage Postdoctoral

Researchers announcement to increase and maintain

a strong cohort of new and talented, NCI-supported,

independent investigators.

Deadline: Feb. 26, 2021.

Funds: $2.7 million in FY2022 to fund up to 16 awards.

The maximum project period is ve years.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; and state, local and Native American

tribal governments; among others.

Areas: NCI said the K99/R00 award is intended for

individuals who require no more than two additional

years of mentored research and career development

(K99 phase) before transitioning to the independent

stage (R00 phase) of the program. The strongest

applicants will propose a well-conceived plan for one to

two years of substantive mentored research and career

development that will help them become competitive

candidates for tenure-track faculty positions and prepare

them to launch robust, independent research programs.

➜ www.grants.gov; FON# RFA-CA-20-055

Exploring the Scientic Value of Existing or New

Sepsis Human Biospecimen Collection (NIGMS)

Scope: The National Institute of General Medical

Sciences seeks (R21/R33) Phased Innovation Award

applications for the Exploring the Scientic Value of

Existing or New Sepsis Human Biospecimen Collections

announcement to support efficient collection, banking

and sharing of biospecimens and associated clinical

data from critically ill patients, ultimately for use in

mechanistic research on sepsis.

Deadline: Nov. 16, 2022.

Funds: For the (R21) phase of up to two years, a total

of $275,000 in direct costs over the two-year (R21)

project period; support for the (R33) phase award may

not exceed two years and is limited to $500,000 in any

single year of the (R33) phase.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; state, local, special district and Native

American tribal governments; and independent school

districts; among others.

Areas: NIGMS said studies should focus on: (1)

assessment of the utility of existing biospecimen

repositories from critically ill and septic patients for

future mechanistic research or (2) development of

improved methods for de novo collection and analysis

of biospecimens from critically ill patients, ultimately for

mechanistic studies of sepsis.

➜ www.grants.gov; FON# PAR-21-077 ■